Concerning the difference of clinicopathological characteristics in patients with specific LncRNA H19 SNP and EGFR phenotype distributions, the presence of LncRNA H19 SNP rs217727 T allele (CT + TT) in patients with EGFR wild-type was correlated to advanced tumor T status (stage III or IV, p = 0.037) and poorer cell differentiation status (poor differentiation, p = 0.012) compared to those EGFR wild-type individuals with LncRNA H19 SNP rs217727 CC allele. Here, H19 is linked to neoplasm.